Role of biogenic amines in certain pathological conditions.
D000208:Acute Disease; D000328:Adult; D000374:Aggression; D001679:Biogenic Amines / Q000378:metabolism*; D001714:Bipolar Disorder / Q000378:metabolism* / Q000628:therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007099:Imipramine / Q000627:therapeutic use; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009526:Nialamide / Q000627:therapeutic use; D012559:Schizophrenia / Q000378:metabolism* / Q000628:therapy
D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D007099:Imipramine; D009526:Nialamide; D002746:Chlorpromazine; D006719:Homovanillic Acid